Chongqing Lummy Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,583.529 million compared to CNY 1,859.010 million a year ago. Operating loss was CNY 346.092 million compared to CNY 168.933 million a year ago. Net loss was CNY 326.764 million compared to CNY 155.198 million a year ago. Basic loss per share from continuing operations was CNY 0.4023 compared to CNY 0.1911 a year ago.